CELL-DYNCN-FREEHGB/NOCLYSE - COFEPRIS Registration 0794R2022 SSA
Access comprehensive regulatory information for CELL-DYNCN-FREEHGB/NOCLYSE (CELL-DYNCN-FREEHGB/NOCLYSE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0794R2022 SSA and manufactured by ABBOTTLABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on August 16, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL CELL-DYN CN-FREE HGB / NOC LYSE, REALIZA LASSIGUIENTES FUNCIONES • HEMOLIZA RÁPIDAMENTE LOSERITROCITOS Y MINIMIZA LOS RESTOS CELULARESRESULTANTES • DESPRENDE EL CITOPLASMA DE LOSLEUCOCITOS,DEJANDOINTACTALAMEMBRANANUCLEAR,PARA PODER CONTAR L
THE CELL-DYN CN-FREE HGB/NOC LYSE PERFORMS THE FOLLOWING FUNCTIONS: • IT RAPIDLY HEMOLYZES ERYTHROCYTES AND MINIMIZES THE RESULTING CELLULAR DEBRIS • IT DETACHES THE CYTOPLASM FROM THE LEUKOCYTES, LEAVING THE NUCLEAR MEMBRANE INTACT, IN ORDER TO BE ABLE TO COUNT THE